Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation
- 30 November 1980
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 46 (5) , 855-862
- https://doi.org/10.1016/0002-9149(80)90440-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- Sustained release procainamide in patients with myocardial infarction.Heart, 1976
- Polymorphic acetylation of procainamide in manClinical Pharmacology & Therapeutics, 1975
- Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotypeClinical Pharmacology & Therapeutics, 1975
- Pharmacokinetics of procainamide intravenously and orally as conventional and slow‐release tabletsClinical Pharmacology & Therapeutics, 1975
- Plasma levels of procaine amide after administration of conventional and sustained-release tabletsEuropean Journal of Clinical Pharmacology, 1973
- Procaine Amide Against Re-Entrant Ventricular ArrhythmiasCirculation, 1973
- Long-Term Use of Procaine Amide following Acute Myocardial InfarctionCirculation, 1973
- Intermittent Intravenous Procaine Amide to Treat Ventricular ArrhythmiasAnnals of Internal Medicine, 1973
- The Use of procaine amide and lidocaine in the treatment of cardiac arrhythmiasProgress in Cardiovascular Diseases, 1969